February 11, 2022 — The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for bebtelovimab, a new monoclonal antibody treatment that shows efficacy against the Omicron variant. The single-dose IV infused drug by Lilly, available only...
February 11, 2022 — The Pfizer-BioNTech COVID-19 vaccine for children ages 6 months to 4 years old is delayed by at least 2 months in the United States. In a joint press release, the firms said they were postponing their request for Emergency Use Authorization (EUA)...
February 9, 2022 — People who would benefit the most from receiving monoclonal antibody (mAb) treatment to fight a COVID infection — older Americans with chronic health conditions — have been the least likely to receive it, according to a new study co-authored by...
N95 and KN95 masks, also known as a respirators, apparently offer the best protection against COVID-19, including the Omicron variant, according to the newly updated Centers for Disease Control and Prevention (CDC) consumer mask website. People at higher risk for...
The BA.2 subvariant of Omicron appears 33% more transmissible than the more common BA.1 Omicron coronavirus variant, according to preprint findings published in a Danish study. Researchers calculated the probability for spreading an infection within a household was...
Some of the human monoclonal antibodies (used clinically to prevent patients from becoming severely ill from COVID-19 disease) may not be protective against the Omicron variant of SARS-CoV-2 now spreading across the United States, researchers reported January 19, 2022...
Several sources of real-world data from across the globe indicate the Omicron coronavirus variant produces a less severe form of COVID-19 disease. In South Africa, where Omicron was identified in November 2021, a private health insurance administrator reported in...
COVID-19 saliva tests appear more effective at detecting the Omicron variant, a recently posted pre-print paper says. Researchers in South Africa tested 382 people who were not sick enough to be hospitalized but still had COVID-19 symptoms. They found that in those...
Updated Booster Guidance for 16-and-17-year-olds On December 9, the Food and Drug Administration authorized third booster shots of the Pfizer-BioNTech Covid-19 vaccine for 16-and-17-year-olds. Hours later CDC Director Walensky signed off on third shots for the age...